Labcorp Holdings (LH) closed at $355.59 on November 2, 2026, down 1.6% from the previous close, on volume of 990,854 shares (30-day average 722,961).
Data as of November 2, 2026.
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focus
Seeking Alpha News (Sun, 1-Nov 9:05 AM ET)
Healthcare sector rallies in October amid rotation away from technology stocks
Seeking Alpha News (Sat, 31-Oct 11:05 AM ET)
Labcorp Holdings (LH) Receives a Hold from Piper Sandler
TipRanks (Fri, 30-Oct 7:56 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Thu, 29-Oct 10:30 PM ET)
TipRanks (Thu, 29-Oct 3:01 PM ET)
Midday Pulse: S&P 500 top intraday gainers
Seeking Alpha News (Thu, 29-Oct 12:05 PM ET)
Ten healthcare stocks with the highest RSI readings as earnings season heats up
Seeking Alpha News (Thu, 29-Oct 10:24 AM ET)
Labcorp Holdings (LH) Receives a Buy from UBS
TipRanks (Thu, 29-Oct 8:20 AM ET)
Seeking Alpha News (Wed, 28-Oct 6:51 AM ET)
Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance
PRNewswire (Wed, 28-Oct 6:51 AM ET)
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Labcorp Holdings trades on the NYSE stock market under the symbol LH.
As of November 2, 2026, LH stock price declined to $355.59 with 990,854 million shares trading.
LH has a beta of -0.19, meaning it tends to be less sensitive to market movements. LH has a correlation of 0.01 to the broad based SPY ETF.
LH has a market cap of $28.87 billion. This is considered a Large Cap stock.
Last quarter Labcorp Holdings reported $4 billion in Revenue and $4.78 earnings per share. This beat revenue expectation by $49 million and exceeded earnings estimates by $.14.
In the last 3 years, LH traded as high as $371.00 and as low as $191.97.
The top ETF exchange traded funds that LH belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
LH has outperformed the market in the last year with a price return of +42.1% while the SPY ETF gained +11.7%. LH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +12.9% and +11.8%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
LH support price is $356.04 and resistance is $366.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LH shares will trade within this expected range on the day.